Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$209.01 - $232.56 $9.48 Million - $10.5 Million
45,341 Added 8.26%
594,595 $130 Million
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $1.39 Million - $1.6 Million
-7,019 Reduced 1.26%
549,254 $125 Million
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $1.95 Million - $2.15 Million
-9,691 Reduced 1.71%
556,273 $112 Million
Q2 2023

Aug 08, 2023

BUY
$211.93 - $241.33 $17 Million - $19.3 Million
80,115 Added 16.49%
565,964 $137 Million
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $1.9 Million - $2.3 Million
8,913 Added 1.87%
485,849 $111 Million
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $365,881 - $447,150
1,796 Added 0.38%
476,936 $112 Million
Q3 2022

Nov 10, 2022

SELL
$204.81 - $262.19 $795,482 - $1.02 Million
-3,884 Reduced 0.81%
475,140 $97.3 Million
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $849,879 - $1.1 Million
-3,974 Reduced 0.82%
479,024 $112 Million
Q1 2022

May 16, 2022

SELL
$259.82 - $298.18 $1.81 Million - $2.08 Million
-6,984 Reduced 1.43%
482,998 $127 Million
Q4 2021

Jan 28, 2022

SELL
$271.6 - $314.21 $756,677 - $875,389
-2,786 Reduced 0.57%
489,982 $154 Million
Q3 2021

Nov 04, 2021

SELL
$274.82 - $308.34 $373,480 - $419,034
-1,359 Reduced 0.28%
492,768 $139 Million
Q2 2021

Jul 28, 2021

BUY
$251.87 - $278.14 $3.65 Million - $4.03 Million
14,481 Added 3.02%
494,127 $136 Million
Q1 2021

May 11, 2021

SELL
$204.88 - $255.03 $5.4 Million - $6.72 Million
-26,364 Reduced 5.21%
479,646 $122 Million
Q4 2020

Feb 10, 2021

SELL
$186.91 - $214.42 $3.32 Million - $3.81 Million
-17,771 Reduced 3.39%
506,010 $103 Million
Q3 2020

Nov 02, 2020

SELL
$167.03 - $201.3 $937,539 - $1.13 Million
-5,613 Reduced 1.06%
523,781 $98.6 Million
Q2 2020

Aug 10, 2020

SELL
$113.31 - $182.44 $571,762 - $920,592
-5,046 Reduced 0.94%
529,394 $87.9 Million
Q1 2020

May 05, 2020

BUY
$104.32 - $195.28 $3.4 Million - $6.36 Million
32,563 Added 6.49%
534,440 $67.5 Million
Q4 2019

Feb 07, 2020

SELL
$163.48 - $173.61 $486,352 - $516,489
-2,975 Reduced 0.59%
501,877 $84.9 Million
Q3 2019

Nov 06, 2019

SELL
$159.77 - $178.1 $1.42 Million - $1.58 Million
-8,891 Reduced 1.73%
504,852 $84.8 Million
Q2 2019

Aug 13, 2019

BUY
$144.16 - $172.9 $163,333 - $195,895
1,133 Added 0.22%
513,743 $88.8 Million
Q1 2019

May 02, 2019

BUY
$123.7 - $156.3 $431,836 - $545,643
3,491 Added 0.69%
512,610 $78.4 Million
Q4 2018

Feb 04, 2019

BUY
$120.82 - $174.09 $2.43 Million - $3.51 Million
20,149 Added 4.12%
509,119 $64.3 Million
Q3 2018

Oct 29, 2018

SELL
$167.67 - $188.27 $382,790 - $429,820
-2,283 Reduced 0.46%
488,970 $84.9 Million
Q2 2018

Jul 25, 2018

SELL
$160.33 - $189.41 $486,601 - $574,859
-3,035 Reduced 0.61%
491,253 $0
Q1 2018

Apr 25, 2018

SELL
$161.53 - $178.11 $29,721 - $32,772
-184 Reduced 0.04%
494,288 $0
Q4 2017

Feb 02, 2018

SELL
$147.99 - $163.95 $2.65 Million - $2.94 Million
-17,922 Reduced 3.5%
494,472 $0
Q3 2017

Oct 27, 2017

BUY
$149.47 - $160.56 $76.6 Million - $82.3 Million
512,394
512,394 $0

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Beck Mack & Oliver LLC Portfolio

Follow Beck Mack & Oliver LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.